Table 2.
Median survival time and survival rates according to clinicopathologic factors (n=99)
| Variable | No. | Median OS | Median PFS | 1-year OS rates | 2-year OS rates |
|---|---|---|---|---|---|
| (Months) | (Months) | (%) | (%) | ||
| Age | |||||
| ≥50 years | 65 | 11.7 | 6.4 | 47.1 | 24.5 |
| <50 years | 34 | 10.7 | 4.6 | 50 | 19.3 |
| Size of the cervical tumor | |||||
| ≥4-cm | 72 | 11.7 | 5.2 | 48.6 | 21.7 |
| < 4-cm | 27 | 11.6 | 8.1 | 46.9 | 25.8 |
| Histological subtype | |||||
| SCC | 80 | 13.0 | 5.7 | 52.5 | 25.9 |
| Non-SCC | 19 | 8.3 | 3.9 | 29.2 | 8.8 |
| ECOG PS | |||||
| 0-2 | 73 | 14.8 | 7.5 | 59.9 | 29.6 |
| 3-4 | 26 | 5.8 | 1.9 | 15.4 | 3.8 |
| Oligometastasis | |||||
| Yes | 36 | 16.6 | 9.3 | 66.7 | 41.2 |
| No | 63 | 10.1 | 4.3 | 37.5 | 12 |
| Bone metastasis | |||||
| Yes | 46 | 14.8 | 7.1 | 65.2 | 31.1 |
| No | 53 | 9.7 | 4.3 | 33.1 | 15.6 |
| Number of organ metastasis | |||||
| Single | 77 | 13.4 | 6.9 | 55.5 | 27.4 |
| Multiple | 22 | 10.0 | 4.3 | 22.7 | 5.7 |
| Lung metastasis | |||||
| Yes | 41 | 10.8 | 4.6 | 35.4 | 12.6 |
| No | 58 | 14.0 | 6.5 | 56.9 | 30 |
| Liver metastasis | |||||
| Yes | 30 | 6.8 | 3.7 | 20 | 8 |
| No | 69 | 14.2 | 7.5 | 60.5 | 29.1 |
| Distant lymph node metastasis | |||||
| Yes | 46 | 10.9 | 4.7 | 43.5 | 15.6 |
| No | 53 | 13.1 | 6.0 | 52.2 | 29 |
| Initial treatment | |||||
| Chemotherapy+local treatment | 49 | 17.3 | 9.4 | 64.8 | 37 |
| Chemotherapy | 15 | 10.7 | 5.9 | 40 | 8.9 |
| Radiotherapy | 11 | 5.9 | 2.4 | 27.3 | 9.1 |
| Supportive care | 24 | 7.3 | 1.8 | 29.2 | 8.3 |
Abbreviations: SCC, Squamous cell carcinoma; ECOG PS, Eastern Cooperative Oncology Group performance status; OS, overall survival; PFS, progression-free survival.